APPLICATION FOR FUNDING
NHSGG&C RESEARCH ENDOWMENT FUND ALLOCATION 2024/25
NHSGG&C-wide Research Endowment Fund will no longer be hospital specific but will otherwise be awarded in agreement with the terms of the original bequests.
The following categories are open for applications:
Cancer
Chest, Heart and Stroke
General
Renal
The usual amount of funding available for each project supported is in the region of £8-15k to support the costs of a specific research project lasting 1 or 2 years. Maximum funding available is £25K per project.
Endowment funds are specifically intended to support early stage researchers to establish their own research portfolio. Experienced researchers (e.g. 7 years post Consultant or Research team leads) should seek funding for their projects from an alternative source
Completed word document applications must be submitted to R&I for review and sign off by finance no later than Friday 27th September 2024. Please send these to Islay Morrison
Following agreement of costings with finance, fully completed and signed off application forms can be submitted. (1 ELECTRONIC COPY & CV).
Electronic signatures will be accepted. Please submit in word document format.
Submission Deadline Friday 11th October 2024
Applications received after this date will not be accepted
Email completed applications to islay.morrison2@ggc.scot.nhs.uk
Finance enquiries please email R&D finance
(R&D.Finance@ggc.scot.nhs.uk)
The Application Form, Finance Form and Guidance Notes can be downloaded below:
———————————————————————————————————————————
Applications are Invited for the Endowment Research Facility Investment fund
Purpose of fund:
Investment in Equipment, Information and Communication Technology CT and physical infrastructure for research facilities and activity”.
Please complete Endowment Funds Block Grant Application Form and submit to michelle.mcdermott@ggc.scot.nhs.uk
Deadline for submission of applications: Wednesday 20 November 2024 for 26 November 2024 meeting
Automatic registration of clinical trials
On the 20th of October the HRA have announced a partnership with ISRCTN, which will enable automatic registration of clinical trials.
Registering studies before the first participant is recruited is one of the pillars of research transparency, it reduces research waste and prevents duplication. A key commitment they make in the Make it Public strategy is to register trials on behalf of sponsors. The aim is to ease the burden on sponsors and help to make transparency easy and the norm.